qualify for glp 1 π’ Two important dates patients interested in GLP-1 medications: β July 1, 2026 β Medicare GLP-1 Bridge Program begins for eligible Medicare Part D beneficiaries. β October 1, 2026 β Zepbound Medicare Bridge Program Explained: GLP-1
Description
Diabetes Care 2012;35:252258

For context, semaglutide alone achieved 14.9% weight loss in the same trial

Further analysis demonstrated a reduction in risk for hospitalization and improved persistence with advanced therapy among GLP-1RA users compared with nonusers

However, we dont yet have studies available that directly compare the two versions

Int Immunopharmacol 74:105649 Bray JJH, Foster-Davies H, Salem A, Hoole AL, Obaid DR, Halcox JPJ, Stephens JW (2021) Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomised controlled trials
